Iridex (IRIX) Capital Expenditures Growth (1y) (2012 - 2026)
Iridex (IRIX) Capital Expenditures Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.63 Bn | 194.02 Bn | 7.27 Bn | -1.00% |
| 2 | Stryker | 127.42 Bn | 123.95 Bn | 4.50 Bn | 10.38% |
| 3 | Medtronic | 118.97 Bn | 109.75 Bn | 6.41 Bn | 6.32% |
| 4 | Boston Scientific | 73.39 Bn | 72.85 Bn | 3.85 Bn | 24.20% |
| 5 | Edwards Lifesciences | 51.97 Bn | 47.72 Bn | 1.35 Bn | 35.70% |
| 6 | Dexcom | 34.32 Bn | 32.37 Bn | 830.00 Mn | -9.99% |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 16.28% |
| 8 | Koninklijke Philips | 26.35 Bn | 23.03 Bn | 4.55 Bn | -4.32% |
| 9 | Steris | 23.04 Bn | 22.56 Bn | 684.20 Mn | -6.52% |
| 10 | Iridex | 13.34 Mn | 8.66 Mn | 4.30 Mn | 300.00% |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 4, 2026 | 205.21% |
| Jan 3, 2026 | -320.86% |
| Sep 27, 2025 | 204.64% |
| Jun 28, 2025 | -213.64% |
| Mar 29, 2025 | -3,300.00% |
| Dec 28, 2024 | -30.50% |
| Sep 28, 2024 | -189.88% |
| Jun 29, 2024 | 37.50% |
| Mar 30, 2024 | -93.02% |
| Dec 30, 2023 | 86.92% |
| Sep 30, 2023 | -76.27% |
| Jul 1, 2023 | -95.35% |
| Apr 1, 2023 | 65.38% |
| Dec 31, 2022 | -27.70% |
| Apr 2, 2022 | 149.06% |
| Apr 3, 2021 | -381.82% |
| Sep 26, 2020 | -165.63% |
| Jun 27, 2020 | 1,400.00% |
| Mar 28, 2020 | -22.22% |
| Dec 28, 2019 | -99.18% |